Your session is about to expire
← Back to Search
Corticosteroid
Ozurdex for Cataract (STAMP Trial)
Phase 4
Waitlist Available
Led By Caesar Luo, MD
Research Sponsored by Bay Area Retina Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after cataract surgery
Awards & highlights
STAMP Trial Summary
This trial compares the effectiveness of two treatments for reducing swelling in the eye after cataract surgery in people with diabetes.
Eligible Conditions
- Cataract
- Diabetic Macular Edema
STAMP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after cataract surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after cataract surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Comparison of central foveal thickness outcomes of anti-vascular endothelial growth factor vs. Ozurdex therapy
Secondary outcome measures
Visual acuity outcomes of anti-vascular endothelial growth factor vs. Ozurdex therapy
Side effects data
From 2015 Phase 4 trial • 45 Patients • NCT0203642422%
vitreous hemorrhage
17%
worsening of cataract
9%
posterior capsule opacification
9%
vitreous syneresis
4%
cranial nerve VI palsy
4%
bradycardia
4%
pneumonia
4%
pyelonephritis
4%
colon cancer
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bevacizumab
Ozurdex
STAMP Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: OzurdexExperimental Treatment1 Intervention
Intravitreal Ozurdex
Group II: Anti-vascular endothelial growth factorActive Control3 Interventions
Intravitreal Bevacizumab, Ranibizumab, or Aflibercept
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ozurdex
2013
Completed Phase 4
~240
Find a Location
Who is running the clinical trial?
Bay Area Retina AssociatesLead Sponsor
2 Previous Clinical Trials
100 Total Patients Enrolled
AllerganIndustry Sponsor
781 Previous Clinical Trials
276,537 Total Patients Enrolled
12 Trials studying Cataract
1,463 Patients Enrolled for Cataract
Caesar Luo, MDPrincipal Investigator - Physician
Alta Bates Summit Medical Center-Alta Bates Campus, Alta Bates Summit Medical Center-Summit Campus, Bay Area Retina AssociatesMedical Group, John Muir Medical Center, Pacific Retina
University Of Rochester School Of Medical & Dentistry (Medical School)
Albert Einstein Medical Center (Residency)
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger